GlobalData on MSN

Moonlight begins SURVEYOR Phase I trial for peanut allergy

The study marks the first-in-human trial of MOON101 and plans to enrol up to 40 participants at various clinical sites across ...

Moonlight Therapeutics Initiates Phase I Clinical Trial (SURVEYOR) of MOON101 for Peanut Allergy

Moonlight Therapeutics, Inc., a clinical stage biotechnology company developing a proprietary intradermal immunotherapy platform for food allergies, today announced the initiation of SURVEYOR, a Phase ...
PharmiWeb

Peanut Allergy Treatment Market Set for Significant Growth by 2031, Driven by Emerging Targeted Therapies and Rising Disease Awareness

Rising prevalence of peanut allergies worldwide, increasing rates of clinical diagnosis, growing acceptance of ...
News Medical

Experts issue clinical guidelines to help early introduction of peanut-containing foods to infants

An expert panel sponsored by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, issued clinical guidelines today to aid health care providers ...